Sean P. Duffy, Chief Executive Officer and Director of Omada Health, Inc. (NASDAQ:OMDA), filed a Form 4 on August 11, 2026, reporting option exercises and open-market sales of common stock executed on August 7 and August 10, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Trading plan in effect: All transactions were made pursuant to a 10b5-1 trading plan adopted by Duffy on March 13, 2026.
  • Options exercised: Duffy exercised stock options covering a total of 21,570 shares across three transactions, at exercise prices of $8.28 and $9.18 per share, with all exercised options reported as 100% vested.
  • Shares sold: A total of 21,570 shares of common stock were disposed of across three sale transactions, at prices of $20.90, $22.80, and a weighted average of $24.8075 (ranging from $24.70 to $25.00).
  • Direct beneficial ownership following transactions: Duffy directly held 411,861 shares of common stock after the reported transactions.
  • Indirect holdings: An additional 851,659 shares are held indirectly in family trusts for the benefit of Duffy's family members; Duffy disclaims beneficial ownership except to the extent of his pecuniary interest.
  • Remaining options: After the exercises, Duffy held 110,532 and 517,308 stock options (right to buy) at exercise prices of $8.28 and $9.18, respectively, expiring May 5, 2031 and February 10, 2032.

Details of CEO Duffy's Option Exercises and Share Sales at Omada Health

According to the filing, Sean P. Duffy exercised stock options and sold shares on two dates: August 7 and August 10, 2026. On August 7, he exercised options to acquire 5,545 shares at $8.28 and 3,083 shares at $9.18 per share, then sold 4,314 shares at $20.90 and another 4,314 shares at $22.80 per share. Following those transactions, his direct beneficial ownership stood at 411,861 shares.

On August 10, 2026, the filing discloses that Duffy exercised options to acquire 12,942 shares at $9.18 per share and sold 12,942 shares at a weighted average price of $24.8075, with individual trade prices ranging from $24.70 to $25.00. The filing notes that Duffy undertakes to provide full trade-by-trade pricing information upon request to the SEC staff, the issuer, or a security holder. His direct share count remained at 411,861 following this second set of transactions.

The filing also reports that 851,659 shares are held indirectly through family trusts for the benefit of Duffy's family members. Duffy, according to the filing, "disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein." The Form 4 was signed by Nathan Salha as Attorney-in-Fact for Sean P. Duffy and filed on August 11, 2026.

What Was Disclosed

The filing reports option exercises totaling 21,570 shares and equal-sized share disposals by Omada Health's CEO on August 7 and August 10, 2026, all conducted under a pre-established 10b5-1 trading plan adopted March 13, 2026.